AKT1 and hemimegalencephaly: At the present stage, our data are underscored by the fact that alterations in the IGF1-PI3K-AKT pathways are observed in tumors of neural origin and disorders associated with severe neurological symptoms such as Tuberous sclerosis complex (TSC) and hemimegalencephaly [34]–[36].